| AGENT REDUCING CARDIAC CONTRACTILE DYSFUNCTION IN EXPERIMENTAL MODEL OF TAKOTSUBO SYNDROME | |
| 2024-07-08 | |
| 专利权人 | AS RUSSIA TOMSK NAT RES MEDICAL CENT (ASTO-Non-standard) |
| 申请日期 | 2024-07-08 |
| 专利号 | RU2833974-C1 |
| 成果简介 | NOVELTY - Invention refers to pharmaceutics and experimental medicine, namely to the use of deferoxamine, which is an iron chelator, as an agent reducing cardiac contractile dysfunction in an experimental model of takotsubo syndrome. USE - Medicine; pharmaceutics. ADVANTAGE - Invention widens the range of products used for the proposed purpose. 1 cl, 2 tbl |
| IPC 分类号 | A61K-031/16 ; A61P-009/04 |
| 国家 | 俄罗斯 |
| 专业领域 | 化学化工 |
| 语种 | 英语 |
| 成果类型 | 专利 |
| 文献类型 | 科技成果 |
| 条目标识符 | http://119.78.100.226:8889/handle/3KE4DYBR/15918 |
| 专题 | 中国科学院新疆生态与地理研究所 |
| 作者单位 | AS RUSSIA TOMSK NAT RES MEDICAL CENT (ASTO-Non-standard) |
| 推荐引用方式 GB/T 7714 | KILIN M,KURBATOV B K,NARYZHNAYA N V,et al. AGENT REDUCING CARDIAC CONTRACTILE DYSFUNCTION IN EXPERIMENTAL MODEL OF TAKOTSUBO SYNDROME. RU2833974-C1[P]. 2024. |
| 条目包含的文件 | 条目无相关文件。 | |||||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论